Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/25/2022* -- Results Q4 2021 -- 1.64 --
02/25/2022* 16:30 EST Earnings Call Q4 2021 -- -- --
11/03/2021 -- Results Q3 2021 2.07 1.80 15.21%
11/03/2021 16:30 EST Earnings Call Q3 2021 -- -- --
08/04/2021 -- Results Q2 2021 1.88 1.64 14.63%
08/04/2021 16:30 EST Earnings Call Q2 2021 -- -- --
05/06/2021 -- Results Q1 2021 1.62 1.54 5.19%
05/06/2021 16:30 EST Earnings Call Q1 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/25/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2021
Beat/Miss Upgrade
Return Since -12.51%
Last FQE 09/30/2021
Next FQE 12/30/2021

Profile

Edit
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
URL http://www.icumed.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 03, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
37.70%
30.65%
46.59%
6.31%
-18.51%
14.63%
10.65%
-11.29%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-7.66%
-7.59%
-78.57%
4.09%
-76.55%
-0.62%
-24.70%
-53.18%
13.39%
-14.78%
-47.58%
48.46%
17.10%
-95.00%
-57.48%
77.60%
-26.12%
--
--
--
--
-85.79%
-73.70%
-79.00%
-32.05%
-35.79%
-38.13%
-31.16%
-24.87%
108.1%
-27.93%
-13.82%
-5.62%
As of January 21, 2022.

Profile

Edit
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU’s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
URL http://www.icumed.com
Investor Relations URL N/A
HQ State/Province California
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Small Cap/Blend
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 03, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
NCAVX 24.84M USD 5.02%
NMAVX 144.38M USD 3.92%
FDHT 210514.0 USD 2.07%
BOSOX 17.91M USD 2.05%
SBRVX 10.21M USD 1.67%
JSEQX 121.64M USD 1.54%
SUN192 21.31M USD 1.39%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Stocktwits ICUI Tweets